sevelameerhydrochloride waymade 400 mg, filmomhulde tabletten
waymade b.v. strawinskylaan 3127 1077 zx amsterdam - sevelameerhydrochloride - filmomhulde tablet - crospovidon (e 1202) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; siliciumdioxide (e 551) ; sorbitol (d-)(e 420) ; titaandioxide (e 171) - sevelamer
sevelameerhydrochloride waymade 800 mg, filmomhulde tabletten
waymade b.v. strawinskylaan 3127 1077 zx amsterdam - sevelameerhydrochloride 800 mg/stuk - filmomhulde tablet - crospovidon (e 1202) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; siliciumdioxide (e 551) ; sorbitol (d-)(e 420) ; titaandioxide (e 171) - sevelamer
methylfenidaathydrochloride teva 10 mg, tabletten
teva b.v. - methylfenidaathydrochloride; - tablet - methylphenidate
methylfenidaathydrochloride teva 10 mg, tabletten
teva b.v. swensweg 5 2031 ga haarlem - methylfenidaathydrochloride 10 mg/stuk - tablet - calcium hydrogen phosphate (hydrate form unknown) (e 341) (ri) ; cellulose, microkristallijn (e 460(i)) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd, calcium hydrogen phosphate (hydrate form unknown) (e 341) (ri) ; cellulose, microkristallijn (e 460) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd - methylphenidate
broomhexinehydrochloride 1,6 mg/ml drank samenwerkende apothekers
samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - broomhexinehydrochloride samenstelling overeenkomend met ; broomhexine - drank - bananensmaakstof ; benzoËzuur (e 210) ; ethanol ; hydroxyethylcellulose ; levomenthol (l- vorm) ; saccharoide natrium x-water (e 954) ; sorbitol (d-)(e 420) ; water, gezuiverd ; wijnsteenzuur, (l (+) vorm) (e 334), - bromhexine
broomhexinehydrochloride 0,8 mg/ml drank samenwerkende apothekers
samenwerkende apothekers nederland b.v. - broomhexinehydrochloride samenstelling overeenkomend met ; broomhexine - drank - ethanol 30 mg/ml ; frambozensmaakstof e.w. 1166 ; sorbitol (d-)(e 420) ; water, gezuiverd, - bromhexine
oxybutyninehydrochloride unichem 2,5 mg tabletten
unichem laboratories limited studio 8b, ard gaoithe commercial centre, ard gaoithe business park, cashel road e91 v2n8 clonm - oxybutyninehydrochloride 2,5 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b), cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b), - oxybutynin
oxybutyninehydrochloride unichem 5 mg tabletten
unichem laboratories limited studio 8b, ard gaoithe commercial centre, ard gaoithe business park, cashel road e91 v2n8 clonm - oxybutyninehydrochloride 5 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b), cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b), - oxybutynin
ambroxol hydrochloride unither pharmaceuticals 30 mg/5 ml or. opl.
unither pharmaceuticals s.a. - ambroxolhydrochloride 6 mg/ml - drank - 30 mg/5 ml - ambroxolhydrochloride 6 mg/ml - ambroxol
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , drievoudige combinatietherapie) als aanvulling op dieet en lichaamsbeweging bij patiënten die onvoldoende gecontroleerd op hun maximale getolereerde dosis van metformine en een enz.). sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.